Cyclerion Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,015,000 over the previous period. Total operating expenses were $9,647,000.
Profit Margin
| 2017 | 0 | -93.92M | |
|---|---|---|---|
| 2018 | 0 | -115.25M | |
| 2019 | 4.50M | -120.97M | -2684.25% |
| 2020 | 2.29M | -72.67M | -3165.07% |
| 2021 | 3.32M | -51.66M | -1556.11% |
| 2022 | 297K | -43.78M | -14742.09% |
| 2023 | 0 | -21.01M |
CYCN Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 297K | 3.32M | 2.29M | 4.50M | 0 | 0 |
Cost of revenue | 0 | 65K | 472K | 0 | 0 | 0 | 1.74M |
Gross profit | 0 | 232K | 2.84M | 2.29M | 4.50M | 0 | -1.74M |
Operating exp. | |||||||
Research and development | 1.51M | 31.49M | 37.63M | 56.41M | 95.14M | 87.71M | 78.80M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.64M | 44.66M | 57.63M | 85.23M | 129.54M | 115.25M | 93.92M |
Operating income | -9.64M | -44.37M | -55.19M | -81.26M | -125.03M | -115.25M | -93.92M |
Other income (expenses), net | -2.94M | 294K | 3.54M | 3.46M | 2.02M | 0 | 0 |
Income before tax | -12.59M | -44.07M | -51.64M | -77.80M | -123.00M | -115.25M | -93.92M |
Income tax expense | 0 | -294K | 16K | -5.13M | -2.02M | 0 | 0 |
Net income | -21.01M | -43.78M | -51.66M | -72.67M | -120.97M | -115.25M | -93.92M |
Earnings per share | |||||||
Basic EPS | -8.99 | -20.15 | -26.4 | -47.8 | -88.37 | -84.42 | -68.8 |
Diluted EPS | -8.99 | -20.15 | -26.4 | -47.8 | -88.37 | -84.42 | -68.8 |
| Data source | Data source | Data source | Data source | Data source |